Identification of a Druggable Target That Predicts Postoperative Crohn’s Disease Recurrence
Sare Verstockt·Timon E. Adolph·Felix Grabherr·Saeed Abdurahiman·Julian Schwärzler·Almina Jukic·Deborah Sarah Jans·Arthur Kaser·Matthias Lenfant·Laura Scheffauer·Nassim Hammoudi·Michael W. Hess·Luis Zundel·Martina Witsch-Baumgartner·André D’Hoore·Gabriele Bislenghi·João Sabino·Séverine Vermeire·Herbert Tilg·Patrizia Moser·Lionel Le Bourhis·Moritz Meyer·Lukas Forer·Bram Verstockt·Robert Koch·Matthieu Allez·Lisa Mayr·Dominique Cazals-Hatem·Richard S. Blumberg·Marc Ferrante·Gert De Hertogh·Kathleen Machiels·Isabelle Cleynen·Peter Willeit
Collectively, our study identifies a druggable biomarker that improves the prediction of endoscopic CD recurrence, potentially guiding patient management and therapy in the future.